Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Rare disease policy of national medical insurance bureau
Rare disease policy of national medical insurance bureau
There is no national medical security system for rare diseases. According to the 2009 edition of the National Essential Drugs List, only three of the 307 drugs can be used for the treatment of rare diseases, and only 57 of the 130 rare drugs listed in China have entered the national medical insurance list, of which only 10 can be fully reimbursed.

Decree No.44 [20 15] issued by the State Council officially brought the review and approval of innovative drugs for the prevention and treatment of AIDS, malignant tumors, major infectious diseases and rare diseases into the accelerated review process. 165438+ 10, CFDA issued "Announcement on Several Policies for Drug Registration Review and Approval" to queue up the applications of the above drugs separately to speed up the review and approval. In terms of medical security, in addition to Zhejiang Province, Shanghai, Ningxia, Qingdao and other places have previously solved the problem of rare diseases through medical insurance and medical assistance.

First, can medical insurance for cancer chemotherapy be reimbursed?

It is possible for medical insurance to reimburse the cost of tumor chemotherapy. According to the national medical insurance policy, cancer is a serious disease, and these drugs should be within the scope of medical insurance reimbursement. Patients are advised to consult the medical insurance department. Whether chemotherapy drugs can be reimbursed depends on whether the drugs used in your city are in the medical insurance catalogue. As long as the drugs in the medical insurance catalogue, whether domestic or imported, are within the scope of reimbursement as long as the drugs have the same name.

Second, which drugs can't be reimbursed for work-related injuries?

The Catalogue of Industrial Injury Insurance Drugs does not contain all therapeutic drugs. In many cases, it is difficult to treat injuries simply by using the drugs listed in the Catalogue of Drugs for Work-related Injury Insurance, especially some anti-infection and surgical AIDS. At this time, we have to use drugs other than the Catalogue of Work-related Injury Insurance Drugs. This situation is definitely not reimbursed.

The relevant legal basis of this article.

Article 28 of People's Republic of China (PRC) Social Insurance Law

Medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency rescue shall be paid by the basic medical insurance fund in accordance with state regulations.

Article 30 of People's Republic of China (PRC) Social Insurance Law

The following medical expenses are not included in the payment scope of the basic medical insurance fund:

(a) shall be paid by the industrial injury insurance fund;

(2) It shall be borne by a third party;

(three) shall be borne by public health;

(4) Go abroad for medical treatment.

Medical expenses that should be borne by a third party according to law. If the third party is unable to pay or cannot determine the third party, the basic medical insurance fund will pay in advance. After the basic medical insurance fund pays in advance, it has the right to recover from the third party.